B. Braun Medical Inc. is a prominent player in the healthcare industry, specializing in infusion therapy, pain management, nutrition, pharmacy admixture, and dialysis. Headquartered in Bethlehem, PA, the company is committed to enhancing patient, clinician, and environmental safety, with a legacy dating back to 1839. As part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap®, and CAPS®, B. Braun Medical leverages expertise and innovation to address critical issues in healthcare. The company's recent $25.00K Debt Financing investment on 27 October 2020 was secured from Ben Franklin Technology Partners of Northeastern Pennsylvania.
With a global presence in 64 countries and employing over 64,000 individuals, the B. Braun Group is dedicated to knowledge exchange, aiming to improve care and lower costs. By developing, manufacturing, and marketing innovative medical products and services, B. Braun Medical remains at the forefront of the healthcare and pharmaceutical industries. For more information, visit bbraunusa.com.
No recent news or press coverage available for B. Braun Medical Inc. (US).